175 related articles for article (PubMed ID: 32665142)
21. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection.
Ito T; Kuriyama N; Kozuka Y; Komatsubara H; Ichikawa K; Noguchi D; Hayasaki A; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
BMC Cancer; 2020 Mar; 20(1):209. PubMed ID: 32164621
[TBL] [Abstract][Full Text] [Related]
22. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
[TBL] [Abstract][Full Text] [Related]
23. Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma.
Kang MJ; Jang JY; Chang J; Shin YC; Lee D; Kim HB; Kim SW
World J Surg; 2016 Oct; 40(10):2451-9. PubMed ID: 27206402
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implication of high grade biliary intraepithelial neoplasia in bile duct resection margins in patients with resected perihilar cholangiocarcinoma.
Shin D; Lee S; Lee JH; Hong SM; Park SY; Yoo C; Lee W; Song KB; Hwang DW; Kim SC
J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):604-613. PubMed ID: 32639085
[TBL] [Abstract][Full Text] [Related]
25. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
[TBL] [Abstract][Full Text] [Related]
26. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
27. Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas.
Nakanishi Y; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Matsui A; Tanaka K; Murakami S; Ebihara Y; Kurashima Y; Narasaki H; Amano T; Shichinohe T; Hirano S
Ann Surg Oncol; 2020 Oct; 27(11):4171-4180. PubMed ID: 32363510
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
Zhang XF; Squires MH; Bagante F; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
Ann Surg Oncol; 2018 May; 25(5):1140-1149. PubMed ID: 29470820
[TBL] [Abstract][Full Text] [Related]
29. Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.
Harada N; Yoshizumi T; Yamashita YI; Soejima Y; Ikegami T; Harimoto N; Itoh S; Maehara Y
Anticancer Res; 2017 Jul; 37(7):3763-3769. PubMed ID: 28668872
[TBL] [Abstract][Full Text] [Related]
30. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
31. Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.
Bagante F; Tran T; Spolverato G; Ruzzenente A; Buttner S; Ethun CG; Groot Koerkamp B; Conci S; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Vitiello G; IJzermans JN; Maithel SK; Poultsides G; Guglielmi A; Pawlik TM
J Am Coll Surg; 2016 May; 222(5):750-759.e2. PubMed ID: 27113512
[TBL] [Abstract][Full Text] [Related]
32. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
[TBL] [Abstract][Full Text] [Related]
33. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
Yan Y; Lu N; Tian W; Liu T
Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
[TBL] [Abstract][Full Text] [Related]
34. Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases.
Buettner S; van Vugt JLA; Gaspersz MP; Coelen RJS; Roos E; Labeur TA; Margonis GA; Ethun CG; Maithel SK; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick BA; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; IJzermans JNM; van Gulik TM; Pawlik TM; Groot Koerkamp B
HPB (Oxford); 2017 Aug; 19(8):735-740. PubMed ID: 28549744
[TBL] [Abstract][Full Text] [Related]
35. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review.
Kambakamba P; Linecker M; Slankamenac K; DeOliveira ML
Am J Surg; 2015 Oct; 210(4):694-701. PubMed ID: 26212390
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic study on metachronous double cholangiocarcinomas of perihilar and subsequent distal bile duct origin.
Shinohara K; Shimoyama Y; Ebata T; Yokoyama Y; Mizuno T; Nakaguro M; Nagino M
Surgery; 2017 Jul; 162(1):84-93. PubMed ID: 28187867
[TBL] [Abstract][Full Text] [Related]
37. Predictive performance of Blumgart T staging for perihilar cholangiocarcinoma in a Japanese center.
Ebata T; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Watanabe N; Nagino M
J Hepatobiliary Pancreat Sci; 2020 Mar; 27(3):132-140. PubMed ID: 31654600
[TBL] [Abstract][Full Text] [Related]
38. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
39. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
[TBL] [Abstract][Full Text] [Related]
40. Transhepatic Direct Approach to the "Limit of the Division of the Hepatic Ducts" Leads to a High R0 Resection Rate in Perihilar Cholangiocarcinoma.
Noji T; Tanaka K; Matsui A; Nakanishi Y; Asano T; Nakamura T; Tsuchikawa T; Okamura K; Hirano S
J Gastrointest Surg; 2021 Sep; 25(9):2358-2367. PubMed ID: 33403562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
